DAVID GUYER
Medical Practice at Penn Plz, New York, NY
License number
New York 171465
Category
Medical Practice
Type
Ophthalmology
Address
Address
1 Penn Plz SUITE 3508, New York, NY 10119
Phone
(212) 845-8208
Personal information
See more information about DAVID GUYER at radaris.comName
Address
Phone
475 Dutch Ridge Rd, Oswego, NY 13126
530 E 76Th St APT 17G, New York, NY 10021
170 W 1St St S, Fulton, NY 13069
293 Burt Rd, Herkimer, NY 13350
170 W 1St St S Uppr, Fulton, NY 13069
Organization information
See more information about DAVID GUYER at bizstanding.comDavid Guyer MD
520 E 70 St, New York, NY 10021
Industry:
Ophthalmology, Cardiologist, Internist
Site:
Phone:
(212) 746-4644 (Phone)
David Robert Guyer
DAVID GUYER, LLC
279 Central Park W #16B, New York, NY 10024
Registration:
May 1, 2007
State ID:
3510563
Business type:
DOMESTIC LIMITED LIABILITY COMPANY
Professional information
Dr. David E Guyer, New York NY - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
New York Weill Cornell Medical Center
520 E 70Th St SUITE 43, New York 10021
(212) 746-2150 (Phone)
520 E 70Th St SUITE 43, New York 10021
(212) 746-2150 (Phone)
Procedures:
Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardiac Myocardial Perfusion Imaging, Coronary Angioplasty, Atherectomy and Stent, Tilt Testing or Cardiac Event Monitors
Conditions:
Aneurysm and Dissection of Heart, Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Ectasia, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congenital Heart Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypertensive Heart Disease, Hypotension, Marfan Syndrome, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Pulmonary Valve Disease, Septal Defect, Syncope, Tricuspid Valve Disease, Venous Hypertension
Languages:
English, Arabic, Italian, Spanish
Hospitals:
New York Weill Cornell Medical Center
520 E 70Th St SUITE 43, New York 10021
NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th St, New York 10065
520 E 70Th St SUITE 43, New York 10021
NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th St, New York 10065
Education:
Medical School
Case Western Reserve University School Of Medicine
Graduated: 1976
Peter Bent Brigham Hospital
Graduated: 1977
Graduated: 1979
Massachusetts General Hospital
Graduated: 1981
Case Western Reserve University School Of Medicine
Graduated: 1976
Peter Bent Brigham Hospital
Graduated: 1977
Graduated: 1979
Massachusetts General Hospital
Graduated: 1981
Methods For Treating Ocular Neovascular Diseases
US Patent:
2007002, Feb 1, 2007
Filed:
Jul 24, 2006
Appl. No.:
11/491818
Inventors:
David Guyer - New York NY, US
Anthony Adamis - Bronxville NY, US
Denis O'Shaughnessy - Mendham NJ, US
Anthony Adamis - Bronxville NY, US
Denis O'Shaughnessy - Mendham NJ, US
International Classification:
A61K 48/00
US Classification:
514044000
Abstract:
Disclosed herein are methods for treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy.
Methods And Compositions For Treating Macular Degeneration
US Patent:
2007002, Feb 1, 2007
Filed:
Jul 24, 2006
Appl. No.:
11/491819
Inventors:
David Guyer - New York NY, US
Anthony Adamis - Bronxville NY, US
Denis O'Shaughnessy - Mendham NJ, US
Anthony Adamis - Bronxville NY, US
Denis O'Shaughnessy - Mendham NJ, US
International Classification:
A61K 48/00
US Classification:
514044000
Abstract:
This invention relates to methods of treating age-related macular degeneration (AMD). In particular, this invention provides methods of treating all forms of wet, age-related macular degeneration. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat wet AMD.
Methods For Treating Ocular Neovascular Diseases
US Patent:
2003017, Sep 11, 2003
Filed:
Nov 8, 2002
Appl. No.:
10/291091
Inventors:
David Guyer - New York NY, US
International Classification:
A61K048/00, A61K031/409, A61N001/30
US Classification:
514/044000, 514/185000, 514/410000, 604/020000
Abstract:
Disclosed herein are methods for treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy.
Methods For Treating Ocular Neovascular Diseases
US Patent:
2004016, Aug 26, 2004
Filed:
Feb 25, 2004
Appl. No.:
10/786491
Inventors:
David Guyer - New York NY, US
International Classification:
A61K039/395, A61K048/00
US Classification:
514/044000, 424/145100
Abstract:
Disclosed herein are methods for treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy.
Methods And Compositions For Treating Macular Degeneration
US Patent:
2005004, Feb 24, 2005
Filed:
Aug 27, 2004
Appl. No.:
10/928533
Inventors:
David Guyer - New York NY, US
Denis O'Shaughnessy - Montville NJ, US
Denis O'Shaughnessy - Montville NJ, US
International Classification:
A61K038/16, C08G063/48, A61K038/18
US Classification:
514007000, 530352000, 525054100
Abstract:
This invention relates to methods of treating age-related macular degeneration (AMD). In particular, this invention provides methods of treating all forms of wet, age-related macular degeneration. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat wet AMD.
Methods And Compositions For Treating Ocular Disorders
US Patent:
2006029, Dec 28, 2006
Filed:
Jun 22, 2006
Appl. No.:
11/472761
Inventors:
Anthony Adamis - Bronxville NY, US
David Guyer - New York NY, US
Marlene Modi - Monmouth Junction NJ, US
David Guyer - New York NY, US
Marlene Modi - Monmouth Junction NJ, US
International Classification:
A61K 48/00
US Classification:
514044000
Abstract:
This invention relates to methods of treating ocular disease. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat such disease.